Cardiology in Review

Journal

Publication Venue For

  • Sex Differences in effectiveness of early CCTA versus standard ED evaluation for acute chest pain.  29. 2013
  • Genetic associations with valvular calcification and aortic stenosis.  29. 2013
  • Effects of antihypertensive drugs on arterial stiffness.  20:259-263. 2012
  • Cardiovascular risk assessment based on quantification of coronary calcium in CCTA.  28. 2012
  • Women and hypertension: What did we learn from the Women's Health Initiative?.  14:267-275. 2006
  • Cardiovascular events in hypertension trials: A focus on perindopril.  23:44-45. 2006
  • Is HDL cholesterol an independent cardiovascular disease risk factor?.  22:42-43. 2005
  • The obesity epidemic: New therapeutic approaches.  22:42-43. 2005
  • Part 3: Overview of study designs.  22:44-45. 2005
  • Essential characteristics of clinical research and strength of evidence.  22:41-43. 2005
  • Clinical research: Definitions, "anatomy and physiology," and universal truth.  21:44-47. 2004
  • Polypharmacy - The good, the bad, and the ugly.  21:34. 2004
  • Use of Aminophylline in the Treatment of Severe Symptomatic Bradycardia Resistant to Atropine.  12:65-68. 2004
  • Revisiting erectile dysfunction in cardiovascular patients.  20:42-43. 2003
  • Safety of PDE 5 inhibition in patients with cardiovascular disease.  19:32-33. 2002
  • SERMs revisited.  19:42. 2002
  • Are there meaningful differences between antihypertensive agents?.  19:1-5. 2002
  • Interview: Suzanne Oparil, MD.  19:5-6. 2002
  • Safety of combination therapy for treatment of dyslipidemia.  18:37-38. 2001
  • Will angiotensin receptor blockers play a role in heart failure treatment?.  17:36-37. 2000
  • Hormone replacement therapy in clinical cardiology.  8:57-64. 2000
  • New physiologic therapy for diabetes.  16:10. 1999
  • Hormone replacement therapy: Should it be routine?.  15:19-20. 1998
  • Clinical trials of herbal supplements to begin.  15:61. 1998
  • Sildenafil: Possible pitfalls for the heart patient.  15:54. 1998
  • Novel approaches to heart failure.  15:15-16. 1998
  • Implications of coronary artery disease plus lower-extremity arterial disease for diabetics.  15:22-28. 1998
  • Estrogen/progestin therapy: Putting the HERS results in context.  15:55. 1998
  • Single-pill combination therapy.  15:8. 1998
  • The sexual dimorphism of high blood pressure.  6:356-363. 1998
  • Toward the ideal target goal for lowering cholesterol.  15:43. 1998
  • Advances in antiplatelet therapy (continued).  14:52. 1997
  • Beta blocking agents in congestive heart failure.  14:20-21. 1997
  • New treatment options for diabetes mellitus.  14:17. 1997
  • Chronobiology and chronotherapeutics.  13:13-17. 1996
  • International Standard Serial Number (issn)

  • 1061-5377
  • 1092-6607
  • Electronic International Standard Serial Number (eissn)

  • 1538-4683